|
Volumn 90, Issue 10, 2012, Pages 1333-1334
|
Should we clean up the reputation of "dirty drugs"?
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
NEW DRUG;
PIPERAZINE DERIVATIVE;
PURINE DERIVATIVE;
SILDENAFIL;
SULFONE;
VASODILATOR AGENT;
DIET SUPPLEMENTATION;
DRUG DESIGN;
EDITORIAL;
HUMAN;
MOLECULARLY TARGETED THERAPY;
DIETARY SUPPLEMENTS;
DRUG DESIGN;
DRUGS, INVESTIGATIONAL;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
MOLECULAR TARGETED THERAPY;
PIPERAZINES;
PURINES;
SULFONES;
VASODILATOR AGENTS;
|
EID: 84875013076
PISSN: None
EISSN: 12057541
Source Type: Journal
DOI: 10.1139/y2012-110 Document Type: Editorial |
Times cited : (14)
|
References (0)
|